Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Herrmann

Showing results (191-200 of 403) with videos related to

Pageof 41
Sort By:
Gastroenterology|March 27, 2007
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapyWolf Peter Hofmann, Andreas Polta, Eva Herrmann, et al.
Ultrasonics|July 27, 2011
Acoustic Radiation Force Impulse-Imaging for the evaluation of the thyroid gland: a limited patient feasibility studyMireen Friedrich-Rust, Olga Romenski, Gesine Meyer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2023
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort studyNiko Kohmer, Shivana Stein, Barbara Schenk, et al.
Journal of Viral Hepatitis|December 4, 2022
The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infectionAissa Miriam Röhrig, Katja Jakobi, Julia Dietz, et al.
Journal of Hepatology|April 25, 2008
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapyPaolo Pugnale, Eva Herrmann, Avidan U Neumann, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2026
Sequential Anticoagulation with LMWH and DOACs in Cirrhotic Portal Vein ThrombosisMelis Onay, Myriam Heilani, Chaarvee Gulia, et al.
BMC Health Services Research|May 1, 2015
Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients--the study design for a multi-centre prospective epidemiologic non-inferiority trialPatrick Meybohm, Dania Patricia Fischer, Christof Geisen, et al.
The Journal of Infectious Diseases|September 1, 2007
Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirinFrancesca Dal Pero, Kwok H Tang, Martina Gerotto, et al.
Journal of Clinical Medicine|April 12, 2022
Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based ChemotherapyMaximilian N Kinzler, Christina Klasen, Falko Schulze, et al.
Journal of Neurosurgery|January 6, 2019
A novel grading system for the prediction of the need for cerebrospinal fluid drainage following posterior fossa tumor surgerySae-Yeon Won, Florian Gessler, Daniel Dubinski, et al.
Pageof 41

Showing results (191-200 of 403) with videos related to

Sort By:
Pageof 41
Gastroenterology|March 27, 2007
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapyWolf Peter Hofmann, Andreas Polta, Eva Herrmann, et al.
Ultrasonics|July 27, 2011
Acoustic Radiation Force Impulse-Imaging for the evaluation of the thyroid gland: a limited patient feasibility studyMireen Friedrich-Rust, Olga Romenski, Gesine Meyer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2023
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort studyNiko Kohmer, Shivana Stein, Barbara Schenk, et al.
Journal of Viral Hepatitis|December 4, 2022
The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infectionAissa Miriam Röhrig, Katja Jakobi, Julia Dietz, et al.
Journal of Hepatology|April 25, 2008
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapyPaolo Pugnale, Eva Herrmann, Avidan U Neumann, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2026
Sequential Anticoagulation with LMWH and DOACs in Cirrhotic Portal Vein ThrombosisMelis Onay, Myriam Heilani, Chaarvee Gulia, et al.
BMC Health Services Research|May 1, 2015
Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients--the study design for a multi-centre prospective epidemiologic non-inferiority trialPatrick Meybohm, Dania Patricia Fischer, Christof Geisen, et al.
The Journal of Infectious Diseases|September 1, 2007
Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirinFrancesca Dal Pero, Kwok H Tang, Martina Gerotto, et al.
Journal of Clinical Medicine|April 12, 2022
Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based ChemotherapyMaximilian N Kinzler, Christina Klasen, Falko Schulze, et al.
Journal of Neurosurgery|January 6, 2019
A novel grading system for the prediction of the need for cerebrospinal fluid drainage following posterior fossa tumor surgerySae-Yeon Won, Florian Gessler, Daniel Dubinski, et al.
Pageof 41